The long range objective of this proposal is to gain insight into the mechanism of proteoglycan assembly and its regulation. Altered proteoglycan synthesis correlates with the onset of several deceases, including neoplastic transformation, atherosclerosis, and various growth disorders associated with connective tissues. Thus, any insight into the mechanisms that cells use to therapeutic agents. To achieve these long- range goals, we propose a series of genetic, biochemical and molecular genetic experiments to probe the biosynthetic pathways of heparan sulfate synthesis in Chinese hamster ovary (CHO) cells. In particular, we plan to execute the following studies: 1. Regulation of GAG composition. We plan to purify alpha-G1cNAc transferase 1, which catalyzes the first committed step in heparan sulfate biosynthesis. We will also examine the way its activity depends on tetrasaccharide and glycopeptide substrates to establish how this enzyme and beta-GaINAc transferase 1 determine if heparan sulfate or chondroitin sulfate assembles at attachment sites in natural proteoglycans. The enzymes will be localized in Golgi sub compartments by glycosylating trapped intermediates. 2. Polymerization of heparan sulfate. Studies of pgsD mutants have established that a single protein contains both alpha.G1cNAc transferase II and G1cUA transferase, which together catalyze heparan sulfate polymerization. Mutant alleles have been found that alter both enzyme activities or only G1cUA transferase. This finding suggests that the mutations in these strains alter different functional domains of the transferase complex. We plan to clone cDNAs corresponding to pgsd alleles to test this hypothesis and to define how the mixed transferase gives rise to heparin sulfate. 3. Modification of heparan sulfate. A new mutant (clone 17) was found to lack 2-O-sulfated uronic acids in heparan sulfate. Enzymatic characterization of this strain and new mutants altered in N-sulfation and 6-O-sulfation will provide insight into how cells regulate the fine structure of heparan sulfate. The mutant also provide important new tools for studying heparan sulfate-protein interactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033063-15
Application #
2021990
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1983-07-01
Project End
1999-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
15
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Thieker, David F; Xu, Yongmei; Chapla, Digantkumar et al. (2018) Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase. Sci Rep 8:11832
Gordts, Philip L S M; Esko, Jeffrey D (2018) The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis. Matrix Biol 71-72:262-282
van Wijk, Xander M; Döhrmann, Simon; Hallström, Björn M et al. (2017) Whole-Genome Sequencing of Invasion-Resistant Cells Identifies Laminin ?2 as a Host Factor for Bacterial Invasion. MBio 8:
Bergfeld, Anne K; Lawrence, Roger; Diaz, Sandra L et al. (2017) N-glycolyl groups of nonhuman chondroitin sulfates survive in ancient fossils. Proc Natl Acad Sci U S A 114:E8155-E8164
Dwyer, Chrissa A; Esko, Jeffrey D (2016) Glycan susceptibility factors in autism spectrum disorders. Mol Aspects Med 51:104-14
Gordts, Philip L S M; Nock, Ryan; Son, Ni-Huiping et al. (2016) ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors. J Clin Invest 126:2855-66
Zaiss, Anne K; Foley, Erin M; Lawrence, Roger et al. (2016) Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo. J Virol 90:412-20
Berbée, Jimmy F P; Boon, Mariëtte R; Khedoe, P Padmini S J et al. (2015) Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun 6:6356
Mooij, Hans L; Bernelot Moens, Sophie J; Gordts, Philip L S M et al. (2015) Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans. J Lipid Res 56:665-73
Wen, Jianzhong; Xiao, Junyu; Rahdar, Meghdad et al. (2014) Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis. Proc Natl Acad Sci U S A 111:15723-8

Showing the most recent 10 out of 98 publications